Agendia BV Announces That its Chief Research Officer Laura van 't Veer has Received a 2007 Breast Cancer Research Founda... ( AMSTERDAM The Netherlands October...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Agendia BV Announces That its Chief Research Officer Laura van 't Veer has Received a 2007 Breast Cancer Research Foundation Award

Date:10/22/2007

AMSTERDAM, The Netherlands, October 22 /PRNewswire/ -- Agendia BV, a world leader in the rapidly evolving field of cancer molecular diagnostics, announced today that its Chief Research Officer Laura van 't Veer has received a prestigious 2007 Breast Cancer Research Foundation Award from the Pink Ribbon Breast Cancer Research Foundation.

The Pink Ribbon 'Breast Cancer Research Foundation' granted in New York awards to 151 international breast cancer researchers with a total value of 32 M$.

Laura van 't Veer received one of the awards together with her colleagues Martine Piccart-Gebhardt, Fatima Cardoso and Beppe Viale for their work on the European 'MINDACT' trial in which specific predictive aspects of MammaPrint(R) breast cancer prognosis assay are further tested.

Since inception in 1993 by Evelyn Lauder, the Breast Cancer Research Foundation has been solely dedicated to providing critical funding for innovative clinical and genetic research at leading medical centers worldwide.

"Laura is deeply committed to convert discoveries made in the academic setting into clinically-relevant products for the benefit of cancer patients. She co-founded Agendia exactly for that purpose. Her meticulous work enabled Agendia to become the first company to obtain clearance from the US FDA for its MammaPrint(R) breast cancer test. We are very pleased to have her and other people of her caliber in our team", said Dr. Bernhard Sixt, CEO of Agendia.

About Agendia

Agendia, located in Amsterdam, the Netherlands, is a world leader in gene expression analysis-based diagnostics with three products on the market. The company focuses on the development and commercialization of diagnostic tests using tumor gene expression profiling. Agendia was the first company to commercialize a prognostic test - MammaPrint(R) - that predicts the risk of breast cancer recurrence. Its second microarray product, CupPrint(R)(x), is a diagnostic test to identify the orig
'/>"/>

SOURCE Agendia BV
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software

Post Your Comments:

(Date:11/24/2009)..., , ST. LOUIS, Nov. 24 /PRNewswire-FirstC... will be presenting at the NASDAQ OMX conference o...7:45 AM US/CST. Interested parties may listen via ...t http://inve s tor.sig m a a ldrich.com/ ...his file. ,, About Sigma-Aldrich: Sigma-A...

(Date:11/24/2009)..., , SHANGHAI, Nov. 24 /PRNewswire-A...te Food & Drug Administration (SFDA) has appro... for its oral insulin project,(Nodlin), an innovat...D,approval allows Biolaxy to initiate its first ph...order characteristic of high blood glucose and poo...

(Date:11/24/2009)..., , DUBLIN, November 24 /PRNewswire-Fir...the global specialty biopharmaceutical company, to...uropean Medicines Agency for,velaglucerase alfa, t...ment,for the treatment of Type 1 Gaucher disease. ...ucerase alfa that has been submitted, with previou...

(Date:11/24/2009)... Chemical Abstracts Service... reports that China,s patent office is now the wor...ions in chemistry. China trailed Japan,s patent of... (WIPO), and the United States Patent and Trademar...d the USPTO in 2005, WIPO in 2006, and exceeded Ja...

Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4 China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2 China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3

[0] Sigma-Aldrich to Present at the NASDAQ OMX 23rd Investor Program on Tuesday, December 1, 2009 [0] Biolaxy Secures IND Approval for Oral Insulin [0] Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease [0] China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information

...orp. , the Illinois-based technology provider that...is elevating a top salesman to handle Berbee,s tra...vice president of sales Steven Schuldt in charge o...ions provider, into CDW. , ,CDW, headquartered in ...rbee on Oct. 11 for approximately $184 million in ...

... Bio Corp. , a Madison-based biotechnology firm, h...U.S., that covers a method of treating patients wi...ion of genes. , ,The patent, titled "Intravascular...livering a wide range of therapeutic nucleic acids...nts a patent already obtained in the United States...

...in an elevator next to a venture capitalist who co...now the first thing about it yet. , ,You have 90 ...emise of the Elevator Pitch Olympics, a yearly eve...year, a panel of eight investors dished out advice...o presented their businesses in front of an audien...

Other Biology Technology:Mirus granted European patent for gene therapy 2 9 tips for making 90 seconds count in an investment pitch 2

CDW names VP to handle Berbee merger Mirus granted European patent for gene therapy 9 tips for making 90 seconds count in an investment pitch

(Date:11/24/2009)...class of ring-shaped protein motors has been uncov...ional Laboratory (Berkeley Lab) using a state-of-t...anced Light Source (ALS). These protein motors pla..., and are vital to the survival of all biological ...uman papillomavirus, which has been linked to cerv...

(Date:11/24/2009)...research on bacterial communities throughout six l...emporal patterns, suggesting that scientists could...limate change in the polar regions. The study, pub...al Academy of Sciences Early Edition, shows that ...nchronously over time, correlating with seasonal s...

(Date:11/23/2009)...of day matters to forest trees dealing with drough... team led by Professor Malcolm Campbell, Universit...arch and colleagues in the department of cell and ...pitalizing on their previous work to decode the ge...d how poplar trees use their 45,000 genes to respo...

Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2 Atomic-level snapshot catches protein motor in action 3 Atomic-level snapshot catches protein motor in action 4 Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2 Time of day matters to thirsty trees, U of T researcher discovers 2 LA BioMed President and CEO will be named president of the American Judicature Society 51250 1 LA BioMed President and CEO will be named president of the American Judicature Society 51250 2 Businesses Community Leaders Invited to Come Together to Examine the Rising Cost of Healthcare 51249 1 Businesses Community Leaders Invited to Come Together to Examine the Rising Cost of Healthcare 51249 2 Calling All Runners 3A Join the Fight Against Cancer 51247 1 Calling All Runners 3A Join the Fight Against Cancer 51247 2

[1] Atomic-level snapshot catches protein motor in action [0] Researchers establish common seasonal pattern among bacterial communities in Arctic rivers [1] Time of day matters to thirsty trees, U of T researcher discovers

... The University of Nottingham are to investigate t...e hope of determining better ways of keeping up ou...d at the School of Graduate Entry Medicine and Hea...e can take and what food we should eat to slow dow... , The team from the Department of Clinical Physi...

...ia, PA, September 11, 2008 People who are asked w...d a "bad" snack might not follow their intentions ...mber/October 2008 issue of the Journal of Nutriti...d that there is a substantial inconsistency betwee...avior. , Participants were asked about their int...

...o available for business travelers, MENLO PARK, C...oice-powered mobile applications, and OAG (Officia...edule and status information to the,airline indust...to provide,mobile applications and services contai...rline industry. Details of the agreement were not ...

Other Biology News:A stronger future for the elderly 2 Making snack food choices 2 Promptu and OAG Team to Deliver Flight Schedule and Status Information on Mobile Devices 2 Promptu and OAG Team to Deliver Flight Schedule and Status Information on Mobile Devices 3

A stronger future for the elderly Making snack food choices Promptu and OAG Team to Deliver Flight Schedule and Status Information on Mobile Devices

Mouse Anti-PPP4C Polyclonal Antibody, Unconjugated from Abnova Corporation

Mouse Anti-Human CAPG Monoclonal Antibody, Unconjugated, Clone 6D6 from Abnova Corporation

GeneSnap from SYNGENE

DISCOVERLIGHT 6XHIS ARRAY from Pierce Biotechnology, Inc.

Biology Products:

Mouse Anti-PPP4C Polyclonal Antibody, Unconjugated from Abnova Corporation Mouse Anti-Human CAPG Monoclonal Antibody, Unconjugated, Clone 6D6 from Abnova Corporation GeneSnap from SYNGENE DISCOVERLIGHT 6XHIS ARRAY from Pierce Biotechnology, Inc.

Agendia BV Announces That its Chief Research Officer Laura van 't Veer has Received a 2007 Breast Cancer Research Founda...( AMSTERDAM The Netherlands October...)